Cytochrome P450s and other enzymes in drug metabolism and toxicity.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E101, doi. 10.1208/aapsj080112
- By:
- Publication type:
- Article
Works matching IS 15507416 AND DT 2006 AND VI 8 AND IP 1
Results: 24
1
2
Current industrial practices of assessing permeability and P-glycoprotein interaction.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E1, doi. 10.1208/aapsj080101
- By:
- Publication type:
- Article
3
The pharmacokinetics of escitalopram in patients with hepatic impairment.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E14, doi. 10.1208/aapsj080102
- By:
- Publication type:
- Article
4
Genetic factors in the predisposition to drug-induced hypersensitivity reactions.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E20, doi. 10.1208/aapsj080103
- By:
- Publication type:
- Article
5
Recent progress in the computational prediction of aqueous solubility and absorption.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E27, doi. 10.1208/aapsj080104
- By:
- Publication type:
- Article
6
The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E41, doi. 10.1208/aapsj080105
- By:
- Publication type:
- Article
7
Mechanisms of drug-induced liver injury.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E48, doi. 10.1208/aapsj080106
- By:
- Publication type:
- Article
8
Role of bioactivation in drug-induced hypersensitivity reactions.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E55, doi. 10.1208/aapsj080107
- By:
- Publication type:
- Article
9
CNS drug delivery: Opioid peptides and the blood-brain barrier.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E76, doi. 10.1208/aapsj080109
- By:
- Publication type:
- Article
10
Safety biomarkers and the clinical development of oncology therapeutics: Considerations for cardiovascular safety and risk management.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E89, doi. 10.1208/aapsj080110
- By:
- Publication type:
- Article
11
Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E95, doi. 10.1208/aapsj080111
- By:
- Publication type:
- Article
12
Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E160, doi. 10.1208/aapsj080119
- By:
- Publication type:
- Article
13
Activation of G-proteins in brain by endogenous and exogenous cannabinoids.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E112, doi. 10.1208/aapsj080113
- By:
- Publication type:
- Article
14
Molecular recognition of opioid receptor ligands.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E126, doi. 10.1208/aapsj080115
- By:
- Publication type:
- Article
15
Receptors of mammalian trace amines.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E138, doi. 10.1208/aapsj080116
- By:
- Publication type:
- Article
16
Blood pressure as an example of a biomarker that functions as a surrogate.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E146, doi. 10.1208/aapsj080117
- By:
- Publication type:
- Article
17
Targeting opioid receptor heterodimers: Strategies for screening and drug development.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E153, doi. 10.1208/aapsj080118
- By:
- Publication type:
- Article
18
Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesics.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E118, doi. 10.1208/aapsj080114
- By:
- Publication type:
- Article
19
Effect of N-1 and N-2 residues on peptide deamidation rate in solution and solid state.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E166, doi. 10.1208/aapsj080120
- By:
- Publication type:
- Article
20
Symbiotic relationship of pharmacogenetics and drugs of abuse.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E174, doi. 10.1208/aapsj080121
- By:
- Publication type:
- Article
21
Commentary: Where and how could biomarkers be used in 2016.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E185, doi. 10.1208/aapsj080122
- By:
- Publication type:
- Article
22
Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E190, doi. 10.1208/aapsj080123
- By:
- Publication type:
- Article
23
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E196, doi. 10.1208/aapsj080124
- By:
- Publication type:
- Article
24
Selectivity and potency of cyclin-dependent kinase inhibitors.
- Published in:
- AAPS Journal, 2006, v. 8, n. 1, p. E204, doi. 10.1208/aapsj080125
- By:
- Publication type:
- Article